Principal Investigator
Perminder Sachdev
Neuropsychiatric Institute,
Prince of Wales Hospital,
Randwick NSW 2031, Australia.
p.sachdev@unsw.edu.au
Summary
Country | Australia |
---|---|
Principal Investigator | Perminder Sachdev |
Contact person (email) | p.sachdev@unsw.edu.au |
Key publication/reference | Sachdev et al. Neurology 2004;62:912-919 Sachdev et al. J Neurol Neurosurg Psychiatry 2014 |
Years in which study conducted | 1997-2005 |
Sample | |
Size | 252 |
Population: Hospital/community | Hospital |
Selection: consecutive/random | Consecutive |
Admit with previous stroke? | Yes |
Admit with TIA? | Yes |
Age range | 49-87 |
Number of centres | 2 |
Control group: number, population, selection | Healthy age-matched volunteers from the same neighbourhood as patients (n=129) |
Assessment | |
Initial: Time and data collected/tests administered | Within 1 week: MedHx, function, VRF, MMSE |
Detailed | 3-6m: NΨ, psychiatric, MRI, IQCODE |
Subsequent (follow-ups) | 1y,3y,5y: NΨ 3y,5y: MRI |
Stroke-related data | European Stroke Scale |
Functional tests/data | SOFAS, ADL, IADL |
Other medical tests/data | APOE, MTHFR genotyping; blood analysis |
Neuropsychological tests | Test battery |
MRI scans, when and how many | 3-6m (67%),3y,5y: T1 and FLAIR |
PET scans | No |
Psychiatric exams/diagnoses | Dementia (DSM-IV), VaD, VCI, Depression (GDS, Hamilton) |
Intervention trialled? | No |
CT=computed tomography scan, MedHx=medical history, VRF=vascular risk factors (hypertension, diabetes, atrial fibrillation, obesity, smoking etc.), NΨ=neuropsychological, TIA=transient ischemic attack, m=month, y=year
Further Details
For more details, see Sydney Stroke Study project.